Biomanufacturing Excellence Act of 2025
House Bill Would Create National Biomanufacturing Center to Boost US Drug Production
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- Congress would direct the National Institute of Standards and Technology to pick one non-federal group to run a national center focused on making medicines using living cells.
- The center would work on “how to scale up” drug manufacturing—moving ideas from a lab into reliable, large-scale production—so the US is less dependent on foreign supply chains.
- It would support better manufacturing standards and shared best practices, aiming to make new drug-making methods more consistent and easier for regulators to review.
- It would help train workers—partnering with colleges and community groups—so more people can operate specialized biotech tools and equipment.
- The bill authorizes $120 million for fiscal year 2026 to help build facilities, run research partnerships, and support training programs.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Milestones
Referred to the House Committee on Science, Space, and Technology.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
2 articlesLawmakers dig in on biopharma manufacturing with bill proposing US center of excellence
Bipartisan lawmakers introduced the Biomanufacturing Excellence Act of 2025 to create a national center under NIST. The bill aims to reduce U.S. dependence on foreign supply chains and ensure a smoother road to commercialization through a public-private biopharmaceutical manufacturing hub.
Proposed biomanufacturing center may create competition among states
The proposed Biomanufacturing Excellence Act would establish a single National Biopharmaceutical Manufacturing Center of Excellence within NIST. With $120 million in authorized funding, the bill is expected to spark intense competition among states to host the new innovation and production hub.
Source Information
Document Type
Congressional Bill
Official Title
Biomanufacturing Excellence Act of 2025
Data Sources
Sponsor
Cosponsors
(12)Analysis generated by AI. Always verify with official sources.